Table of Contents:
  • Market participants and competition
  • Regulatory and enforcement framework
  • Assessing market power
  • Pharmaceutical mergers
  • Joint ventures and licensing agreements
  • Antitrust analysis of pharmaceutical manufacturer conduct
  • Antitrust issues in the distribution of pharmaceutical products
  • Economists' use of data in pharmaceutical antitrust cases.